"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Astrazeneca Pharma India Ltd
Industry : Pharmaceuticals - Multinational	Chairman : Shilpa Divekar Nirula
Home : MNC Associate	Book Value: 349.116
BSE Code : 506820	Market Cap: 18770.5
NSE Code : ASTRAZEN	P / E : 108.2

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025
Type	1Qtr	4Qtr	3Qtr	2Qtr
Net Sales	682.79	578.61	611.57	559.09
Other Income	9.23	5.95	6.61	6.17
Total Income	692.02	584.56	618.18	565.26
Total Expenditure	634.09	518.78	566.74	489.20
Operating Profit	57.93	65.78	51.44	76.06
Interest	1.95	2.04	1.06	0.67
Gross Profit	55.98	63.74	50.38	75.39
Depreciation	5.23	5.60	3.84	2.57
Tax	10.87	14.31	4.00	19.01
Deferred Tax	1.95	-1.05	9.95	-0.41
Reported Profit After Tax	37.93	44.88	32.59	54.22

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView